Absolute Eosinophil Count May Be an Optimal Peripheral Blood Marker to Identify the Risk of Immune-Related Adverse Events in Advanced Malignant Tumors Treated with PD-1/PD-L1 Inhibitors: a Retrospective Analysis
World Journal of Surgical Oncology（2022）
Key words
Immunotherapy,Immune-related adverse events,Neutrophil-to-lymphocyte ratio,Platelet-to-lymphocyte ratio,Absolute eosinophil count,Predictive markers
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined